Literature DB >> 19774673

Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry.

A Kiss1, J Bundzikova, Z Pirnik, J D Mikkelsen.   

Abstract

Acute administration of antipsychotics elicits regionally distinct patterns of Fos expression in the rat brain. Stimulation of oxytocin (OXY) and vasopressin (AVP) release in the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei indicates that antipsychotics may play a role in autonomic, neuroendocrine, and behavioral processes. This study was focused to reveal the responsiveness of hypothalamic OXY- and AVP- producing magnocellular neurons, in terms of quantitative and topographical distinctions, to antipsychotics displaying different pharmacological profiles. Naive male Wistar rats were injected intraperitoneally with haloperidol (1 mg/kg), clozapine (30 mg/kg), olanzapine (30 mg/kg), risperidone (2mg/kg), and vehicle (5% chremophor) and were sacrificed 60 min later by a fixative. Fos, Fos/OXY, and Fos/AVP labelings were visualized by immunohistochemistry in the SON, 5 accessory (ACS) cell groups, and 4 distinct PVN subdivisions using a computerized light microscope. Most apparent activation of single Fos, Fos/OXY, and Fos/AVP cells was induced by clozapine and olanzapine; effects of risperidone and haloperidol were substantially lower; no colocalizations were revealed in naive or vehicle treated control rats. The data indicate the existence of a substantial diversity in the stimulatory effect of the selected antipsychotics on quantity of Fos, Fos/OXY, and Fos/AVP immunostainings with the preferential action of the atypicals clozapine over olanzapine and little effects of risperidone and haloperidol. Variabilities in Fos distribution in the PVN, SON, and ACS induced by antipsychotics may be helpful to understand more precisely the extent of their extra-forebrain actions with possible presumption of their functional impact and side effect consequences. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19774673     DOI: 10.1002/jnr.22226

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  19 in total

1.  Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice.

Authors:  Megan Beauchemin; Ramaz Geguchadze; Anyonya R Guntur; Kathleen Nevola; Phuong T Le; Deborah Barlow; Megan Rue; Calvin P H Vary; Christine W Lary; Katherine J Motyl; Karen L Houseknecht
Journal:  Pharmacol Res       Date:  2019-12-23       Impact factor: 7.658

2.  Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.

Authors:  Kai Macdonald; David Feifel
Journal:  Acta Neuropsychiatr       Date:  2011-12-19       Impact factor: 3.403

3.  Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia.

Authors:  Gregory P Strauss; William R Keller; James I Koenig; Sara K Sullivan; James M Gold; Robert W Buchanan
Journal:  Schizophr Res       Date:  2015-01-22       Impact factor: 4.939

Review 4.  Potential of Oxytocin in the Treatment of Schizophrenia.

Authors:  Paul D Shilling; David Feifel
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

5.  Endogenous oxytocin response to film scenes of attachment and loss is pronounced in schizophrenia.

Authors:  Lucas G Speck; Johanna Schöner; Felix Bermpohl; Andreas Heinz; Jürgen Gallinat; Tomislav Majic; Christiane Montag
Journal:  Soc Cogn Affect Neurosci       Date:  2019-01-04       Impact factor: 3.436

6.  Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c-Fos immunoreactivity.

Authors:  Changjiu Zhao; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2012-08-31       Impact factor: 3.533

7.  Neuroleptics Affect Neuropeptide S and NPSR mRNA Levels in the Rat Brain.

Authors:  Artur Pałasz; Ewa Rojczyk
Journal:  J Mol Neurosci       Date:  2015-07-31       Impact factor: 3.444

Review 8.  A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.

Authors:  David Feifel; Paul D Shilling; Kai MacDonald
Journal:  Biol Psychiatry       Date:  2015-08-13       Impact factor: 13.382

9.  Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis.

Authors:  Leah H Rubin; C Sue Carter; Jeffrey R Bishop; Hossein Pournajafi-Nazarloo; Margret S H Harris; Scot K Hill; James L Reilly; John A Sweeney
Journal:  Schizophr Res       Date:  2013-03-07       Impact factor: 4.939

10.  Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms.

Authors:  Meghan Miller; Karen L Bales; Sandra L Taylor; Jong Yoon; Caroline M Hostetler; Cameron S Carter; Marjorie Solomon
Journal:  Autism Res       Date:  2013-02-14       Impact factor: 5.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.